The social epidemiology of human immunodeficiency virus/acquired immunodeficiency syndrome

Epidemiologic Reviews

Volumn 26, Issue , 2004, Pages 22-35

  Poundstone, K E ^a   Strathdee, S A ^a   Celentano, David D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CULTURAL ANTHROPOLOGY; DATA BASE; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEGAL ASPECT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL ASPECT; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CONTINENTAL POPULATION GROUPS; HIV; HUMANS; INCIDENCE; MODELS, THEORETICAL; RISK FACTORS; SEX FACTORS; SOCIAL ENVIRONMENT;

EID: 3042720557     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/epirev/mxh005     Document Type: Article

References (194)

1. Berkman LF, Kawachi I. A historical framework for social epidemiology. In: Berkman LF, Kawachi I, eds. Social epidemiology. New York, NY: Oxford University Press, 2000:3-12.
2. Krieger N. A glossary for social epidemiology. J Epidemiol Community Health 2001;55:693-700.
3. Fee E, Krieger N. Understanding AIDS: historical interpretations and the limits of biomedical individualism. Am J Public Health 1993;83:1477-86.
4. Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav 1995;Spec No:80-94.
5. Halloran ME, Struchiner CJ. Study designs for dependent happenings. Epidemiology 1991;2:331-8.
6. Koopman JS, Longini IM, Jr. The ecological effects of individual exposures and nonlinear disease dynamics in populations. Am J Public Health 1994;84:836-42.
7. Aral SO. Understanding racial-ethnic and societal differentials in STI. Sex Transm Infect 2002;78:2-4.
8. Garnett GP. The basic reproductive rate of infection and the course of HIV epidemics. AIDS Patient Care STDS 1998;12:435-49.
9. Tylor E. Primitive culture. London, United Kingdom: John Murray, 1871.
10. Creswell JW. Research design: qualitative, quantitative, and mixed methods approaches. Thousand Oaks, CA: Sage Publications, 2003.
11. Needle RH, Trotter RT, Singer M, et al. Rapid assessment of the HIV/AIDS crisis in racial and ethnic minority communities: an approach for timely community interventions. Am J Public Health 2003;93:970-9.
12. Rhodes T, Stimson GV, Fitch C, et al. Rapid assessment, injecting drug use, and public health. Lancet 1999;354:65-8.
13. World Health Organization-Programme on Substance Abuse. The rapid assessment and response guide on injection drug use. Stimson GV, Fitch C, Rhodes T, eds. Geneva, Switzerland: World Health Organization, 1998:104-112.
14. Beyrer C, Razak MH, Lisam K, et al. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS 2000;14:75-83.
15. Panda S, Chatterjee A, Bhattacharya SK, et al. Transmission of HIV from injecting drug users to their wives in India. Int J STD AIDS 2000;11:468-73.
16. Auerbach DM, Darrow WW, Jaffe HW, et al. Cluster of cases of the acquired immune deficiency syndrome. Patients linked by sexual contact. Am J Med 1984;76:487-92.
17. Rothenberg R. How a net works: implications of network structure for the persistence and control of sexually transmitted diseases and HIV. Sex Transm Dis 2001;28:63-8.
18. Neaigus A. The network approach and interventions to prevent HIV among injection drug users. Public Health Rep 1998;113(suppl 1):140-50.
19. Berkman LF, Glass T. Social integration, social networks, social support, and health. In: Berkman LF, Kawachi I, eds. Social epidemiology. New York, NY: Oxford University Press, 2000:137-73.
20. Friedman SR, Kottiri BJ, Neaigus A, et al. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol 2000;152:913-22.
21. Curtis R, Friedman SR, Neaigus A, et al. Street-level drug markets: network structure and HIV risk. Social Networks 1995;17:229-49.
22. Thomas JC, Tucker MJ. The development and use of the concept of a sexually transmitted disease core. J Infect Dis 1996;174(suppl 2):S134-S143.
23. Friedman SR, Neaigus A, Jose B, et al. Sociometric risk networks and risk for HIV infection. Am J Public Health 1997;87:1289-96.
24. Blower SM, McLean AR. Mixing ecology and epidemiology. Proc R Soc Lond B Biol Sci 1991;245:187-92.
25. Blower SM, Hartel D, Dowlatabadi H, et al. Drugs, sex and HIV: a mathematical model for New York City. Philos Trans R Soc Lond B Biol Sci 1991;331:171-87.
26. Morris M, Kretzschmar M. Concurrent partnerships and transmission dynamics in networks. Social Networks 1995;17:299-318.
27. Morris M, Podhisita C, Wawer MJ, et al. Bridge populations in the spread of HIV/AIDS in Thailand. AIDS 1996;10:1265-71.
28. Morris M, Kretzschmar M. Concurrent partnerships and the spread of HIV. AIDS 1997;11:641-8.
29. Service S, Blower SM. HIV transmission in sexual networks: an empirical analysis. Proc R Soc Lond B Biol Sci 1995;260:237-44.
30. Rothenberg RB, Potterat JJ, Woodhouse DE, et al. Choosing a centrality measure: epidemiologic correlates in the Colorado Springs study of social networks. Social Networks 1995;17:273-97.
31. Laumann EO, Youm Y. Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation. Sex Transm Dis 1999;26:250-61.
32. Garnett GP, Anderson RM. Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes. Philos Trans R Soc Lond B Biol Sci 1993;342:137-59.
33. Zaric GS. Random vs. nonrandom mixing in network epidemic models. Health Care Manag Sci 2002;5:147-55.
34. Potterat JJ, Muth SQ, Brody S. Evidence undermining the adequacy of the HIV reproduction number formula. Sex Transm Dis 2000;27:644-5.
35. Bell DC, Montoya ID, Atkinson JS, et al. Social networks and forecasting the spread of HIV infection. J Acquir Immune Defic Syndr 2002;31:218-29.
36. Latkin CA, Mandell W, Vlahov D, et al. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE Study. Am J Community Psychol 1996;24:341-64.
37. Latkin CA, Forman V, Knowlton A, et al. Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med 2003;56:465-76.
38. Lovell AM. Risking risk: the influence of types of capital and social networks on the injection practices of drug users. Soc Sci Med 2002;55:803-21.
39. Sherman SG, Latkin CA. Intimate relationship characteristics associated with condom use among drug users and their sex partners: a multilevel analysis. Drug Alcohol Depend 2001;64:97-104.
40. Kelly JA, St Lawrence JS, Diaz YE, et al. HIV risk behavior reduction following intervention with key opinion leaders of population: an experimental analysis. Am J Public Health 1991;81:168-71.
41. Kelly JA, St Lawrence JS, Stevenson LY, et al. Community AIDS/HIV risk reduction: the effects of endorsements by popular people in three cities. Am J Public Health 1992;82:1483-9.
42. Sikkema KJ, Kelly JA, Winett RA, et al. Outcomes of a randomized community-level HIV prevention intervention for women living in 18 low-income housing developments. Am J Public Health 2000;90:57-63.
43. Wallace R. Traveling waves of HIV infection on a low dimensional 'socio-geographic' network. Soc Sci Med 1991;32:847-52.
44. Potterat JJ, Rothenberg RB, Woodhouse DE, et al. Gonorrhea as a social disease. Sex Transm Dis 1985;12:25-32.
45. Barr RG, Diez-Roux AV, Knirsch CA, et al. Neighborhood poverty and the resurgence of tuberculosis in New York City, 1984-1992. Am J Public Health 2001;91:1487-93.
46. Zierler S, Krieger N, Tang Y, et al. Economic deprivation and AIDS incidence in Massachusetts. Am J Public Health 2000;90:1064-73.
47. Acevedo-Garcia D. Residential segregation and the epidemiology of infectious diseases. Soc Sci Med 2000;51:1143-61.
48. Cohen D, Spear S, Scribner R, et al. "Broken windows" and the risk of gonorrhea. Am J Public Health 2000;90:230-6.
49. Cohen DA, Mason K, Bedimo A, et al. Neighborhood physical conditions and health. Am J Public Health 2003;93:467-71.
50. Kawachi I, Berkman LF, eds. Neighborhoods and health. New York, NY: Oxford University Press, 2003.
51. Diez Roux AV. Investigating neighborhood and area effects on health. Am J Public Health 2001;91:1783-9.
52. Diez Roux AV. Invited commentary: places, people, and health. Am J Epidemiol 2002;155:516-19.
53. Macintyre S, Ellaway A, Cummins S. Place effects on health: how can we conceptualise, operationalise and measure them? Soc Sci Med 2002;55:125-39.
54. O'Campo P. Invited commentary: advancing theory and methods for multilevel models of residential neighborhoods and health. Am J Epidemiol 2003;157:9-13.
55. Massey DS. The age of extremes: concentrated affluence and poverty in the twenty-first century. Demography 1996;33:395-412.
56. Fischer MJ. The relative importance of income and race in determining residential outcomes in U.S. urban areas, 1970-2000. Urban Affairs Rev 2003;38:669-96.
57. Massey DS, Eggers ML. The ecology of inequality: minorities and the concentration of poverty, 1970-1980. Am J Sociol 1990;95:1153-88.
58. Wallace R. Social disintegration and the spread of AIDS: thresholds for propagation along 'sociogeographic' networks. Soc Sci Med 1991;33:1155-62.
59. Wallace R, Fullilove MT. AIDS deaths in the Bronx 1983-1988: spatiotemporal analysis from a sociogeographic perspective. Environ Plan A 1991;23:1, 701-1, 723.
60. Wallace R. Social disintegration and the spread of AIDS-II. Meltdown of sociogeographic structure in urban minority neighborhoods. Soc Sci Med 1993;37:887-96.
61. Wallace R, Wallace D. U.S. apartheid and the spread of AIDS to the suburbs: a multi-city analysis of the political economy of spatial epidemic threshold. Soc Sci Med 1995;41:333-45.
62. Wallace R, Wallace D. Socioeconomic determinants of health: community marginalisation and the diffusion of disease and disorder in the United States. BMJ 1997;314:1341-5.
63. Wallace R. A fractal model of HIV transmission on complex socio-geographic networks. Part 2: spread from a ghettoized 'core group' into a 'general population'. Environ Plan A 1994;26:767-78.
64. Fife D, Mode C. AIDS incidence and income. J Acquir Immune Defic Syndr 1992;5:1105-10.
65. Fordyce EJ, Shum R, Singh TP, et al. Economic and geographic diversity in AIDS incidence among HIV exposure groups in New York City: 1983 to 1995. AIDS Public Policy J 1998;13:103-14.
66. Simon PA, Hu DJ, Diaz T, et al. Income and AIDS rates in Los Angeles County. AIDS 1995;9:281-4.
67. Rapiti E, Porta D, Forastiere F, et al. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy. Lazio AIDS Surveillance Collaborative Group. Epidemiology 2000;11:496-501.
68. Wallace RG. AIDS in the HAART era: New York's heterogeneous geography. Soc Sci Med 2003;56:1155-71.
69. McFarland W, Chen S, Hsu L, et al. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. J Acquir Immune Defic Syndr 2003;33:96-103.
70. Kawachi I. Income inequality and health. In: Berkman LF, Kawachi I, eds. Social epidemiology. New York, NY: Oxford University Press, 2000:76-94.
71. Acevedo-Garcia D. Zip code-level risk factors for tuberculosis: neighborhood environment and residential segregation in New Jersey, 1985-1992. Am J Public Health 2001;91:734-41.
72. Cohen CJ, Dawson MC. Neighborhood poverty and African American politics. Am Polit Sci Rev 1993;87:286-302.
73. Wilson JQ, Kelling GL. Broken windows: the police and neighborhood safety. The Atlantic Monthly 1982;249:29-38.
74. Latkin C, Mandell W, Vlahov D, et al. My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol 1994;22:415-30.
75. Latkin C, Mandell W, Vlahov D, et al. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:273-80.
76. Coleman JS. Social capital and the creation of human capital. Am J Sociol 1988;94:S95-S120.
77. Kawachi I, Berkman L. Social cohesion, social capital, and health. In: Berkman LF, Kawachi I, eds. Social epidemiology. New York, NY: Oxford University Press, 2000:174-90.
78. Holtgrave DR, Crosby RA. Social capital, poverty, and income inequality as predictors of gonorrhoea, syphilis, chlamydia and AIDS case rates in the United States. Sex Transm Infect 2003;79:62-4.
79. Campbell C, Williams B, Gilgen D. Is social capital a useful conceptual tool for exploring community level influences on HIV infection? An exploratory case study from South Africa. AIDS Care 2002;14:41-54.
80. Farmer P. On suffering and structural violence: social and economic rights in the global era. Pathologies of power: health, human rights, and the new war on the poor. Berkeley, CA: University of California Press, 2003:29-50.
81. Laveist TA. On the study of race, racism, and health: a shift from description to explanation. Int J Health Serv 2000;30:217-19.
82. Jones CP, LaVeist TA, Lillie-Blanton M. "Race" in the epidemiologic literature: an examination of the American Journal of Epidemiology, 1921-1990. Am J Epidemiol 1991;134:1079-84.
83. Cooper RS, Kaufman JS, Ward R. Race and genomics. N Engl J Med 2003;348:1166-70.
84. Kaufman JS, Cooper RS. Commentary: considerations for use of racial/ethnic classification in etiologic research. Am J Epidemiol 2001;154:291-8.
85. Mays VM, Ponce NA, Washington DL, et al. Classification of race and ethnicity: implications for public health. Annu Rev Public Health 2003;24:83-110.
86. Krieger N. Does racism harm health? Did child abuse exist before 1962? On explicit questions, critical science, and current controversies: an ecosocial perspective. Am J Public Health 2003;93:194-9.
87. Smith DK, Gwinn M, Selik RM, et al. HIV/AIDS among African Americans: progress or progression? AIDS 2000;14:1237-48.
88. Centers for Disease Control and Prevention. HIV/AIDS among Hispanics in the United States, 2002. (http:// www.cdc.gov/hiv/pubs/facts/hispanic.pdf). (Accessed September 23, 2003).
89. Karon JM, Fleming PL, Steketee RW, et al. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001;91:1060-8.
90. Haverkos HW, Turner JF Jr, Moolchan ET, et al. Relative rates of AIDS among racial/ethnic groups by exposure categories. J Natl Med Assoc 1999;91:17-24.
91. Friedman SR, Chapman TF, Perlis TE, et al. Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996. J Acquir Immune Defic Syndr 1999;22:83-91.
92. Ellen JM, Aral SO, Madger LS. Do differences in sexual behaviors account for the racial/ethnic differences in adolescents' self-reported history of a sexually transmitted disease? Sex Transm Dis 1998;25:125-9.
93. Hahn RA, Magder LS, Aral SO, et al. Race and the prevalence of syphilis seroreactivity in the United States population: a national sero-epidemiologic study. Am J Public Health 1989;79:467-70.
94. Battjes RJ, Pickens RW, Haverkos HW, et al. HIV risk factors among injecting drug users in five US cities. AIDS 1994;8:681-7.
95. Krieger N. Discrimination and health. In: Berkman LF, Kawachi I, eds. Social epidemiology. New York, NY: Oxford University Press, 2000:36-75.
96. Kottiri BJ, Friedman SR, Neaigus A, et al. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr 2002;30:95-104.
97. Adimora AA, Schoenbach VJ. Contextual factors and the black-white disparity in heterosexual HIV transmission. Epidemiology 2002;13:707-12.
98. Thomas JC, Gaffield ME. Social structure, race, and gonorrhea rates in the southeastern United States. Ethn Dis 2003;13:362-8.
99. UNAIDS/WHO fact sheet, 2003. (http://www.unaids.org/ html/pub/Topics/ Epidemiology/RegionalEstimates2002_en_pdf.htm). (Accessed September 8, 2003).
100. Zierler S, Krieger N. Reframing women's risk: social inequalities and HIV infection. Annu Rev Public Health 1997;18:401-36.
101. Carovano K. More than mothers and whores: redefining the AIDS prevention needs of women. Int J Health Serv 1991;21:131-42.
102. Allen S, Serufilira A, Bogaerts J, et al. Confidential HIV testing and condom promotion in Africa. Impact on HIV and gonorrhea rates. JAMA 1992;268:3338-43.
103. Exner T, Ehrhardt AA, Seal DW. A review of HIV interventions for at risk women. AIDS Behav 1997;1:93-124.
104. Serwadda D, Gray RH, Wawer MJ, et al. The social dynamics of HIV transmission as reflected through discordant couples in rural Uganda. AIDS 1995;9:745-50.
105. Konde-Lule JK, Wawer MJ, Sewankambo NK, et al. Adolescents, sexual behaviour and HIV-1 in rural Rakai district, Uganda. AIDS 1997;11:791-9.
106. Ruiz MS, Gable AR, Kaplan EH, et al. No time to lose: getting more from HIV prevention. Washington, DC: National Academy Press, 2001.
107. Valdiserri RO. HIV/AIDS stigma: an impediment to public health. Am J Public Health 2002;92:341-2.
108. Janssen RS, Holtgrave DR, Valdiserri RO, et al. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am J Public Health 2001;91:1019-24.
109. Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol 2001;27:363-85.
110. Herek GM, Mitnick L, Burris S, et al. Workshop report: AIDS and stigma: a conceptual framework and research agenda. AIDS Public Policy J 1998;13:36-47.
111. Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med 2003;57:13-24.
112. Herek GM, Capitanio JP, Widaman KF. HIV-related stigma and knowledge in the United States: prevalence and trends, 1991-1999. Am J Public Health 2002;92:371-7.
113. Parker RG, Easton D, Klein CH. Structural barriers and facilitators in HIV prevention: a review of international research. AIDS 2000;14(suppl 1):S22-S32.
114. Sweat MD, Denison JA. Reducing HIV incidence in developing countries with structural and environmental interventions. AIDS 1995;(9 suppl A):S251-S257.
115. Klein SJ, Karchner WD, O'Connell DA. Interventions to prevent HIV-related stigma and discrimination: findings and recommendations for public health practice. J Public Health Manag Pract 2002;8:44-53.
116. Altman D. Power and community: organizational and cultural responses to AIDS. London, United Kingdom: Taylor and Francis, 1994.
117. Daniel H, Parker R. Sexuality, politics, and AIDS in Brazil. London, United Kingdom: Falmer Press, 1993.
118. Epstein S. Impure science: AIDS, activism and the politics of knowledge. Berkeley, CA: University of California Press, 1996.
119. Rogers EM. Diffusion of innovations. New York, NY: Free Press, 1983.
120. Dearing JW, Meyer G, Rogers EM. Diffusion theory and HIV risk behavior change. In: DiClimente RJ, Peterson JL, eds. Preventing AIDS: theories and methods of behavioral interventions. New York, NY: Plenum Press, 1994.
121. Burris S. Law as a structural factor in the spread of communicable disease. Houston Law Rev 1999;36:1755-86.
122. Burris S, Kawachi I, Sarat A. Integrating law and social epidemiology. J Law Med Ethics 2002;30:510-21.
123. Friedman SR, Perlis T, Des Jarlais DC. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health 2001;91:791-3.
124. Lazzarini Z, Klitzman R. HIV and the law: integrating law, policy, and social epidemiology. J Law Med Ethics 2002;30:533-47.
125. Decosas J, Kane F, Anarfi JK, et al. Migration and AIDS. Lancet 1995;346:826-8.
126. Kane F, Alary M, Ndoye I, et al. Temporary expatriation is related to HIV-1 infection in rural Senegal. AIDS 1993;7:1261-5.
127. Pison G, Le Guenno B, Lagarde E, et al. Seasonal migration: a risk factor for HIV infection in rural Senegal. J Acquir Immune Defic Syndr 1993;6:196-200.
128. Perrin L, Kaiser L, Yerly S. Travel and the spread of HIV-1 genetic variants. Lancet Infect Dis 2003;3:22-7.
129. Gysels M, Pool R, Bwanika K. Truck drivers, middlemen and commercial sex workers: AIDS and the mediation of sex in south west Uganda. AIDS Care 2001;13:373-85.
130. Singh YN, Malaviya AN. Long distance truck drivers in India: HIV infection and their possible role in disseminating HIV into rural areas. Int J STD AIDS 1994;5:137-8.
131. Lacerda R, Gravato N, McFarland W, et al. Truck drivers in Brazil: prevalence of HIV and other sexually transmitted diseases, risk behavior and potential for spread of infection. AIDS 1997;11(suppl 1):S15-S19.
132. Bwayo J, Plummer F, Omari M, et al. Human immunodeficiency virus infection in long-distance truck drivers in east Africa. Arch Intern Med 1994;154:1391-6.
133. McLigeyo SO. Long distance truck driving: its role in the dynamics of HIV/AIDS epidemic. East Afr Med J 1997;74:341-2.
134. Jochelson K, Mothibeli M, Leger JP. Human immunodeficiency virus and migrant labor in South Africa. Int J Health Serv 1991;21:157-73.
135. Vlahov D, Galea S. Urbanization, urbanicity, and health. J Urban Health 2002;79(suppl 1):S1-S12.
136. Over M. The effects of societal variables on urban rates of HIV infection in developing countries: an exploratory analysis. In: Ainsworth M, Fransen L, Over M, eds. Confronting AIDS: evidence from the developing world. Washington, DC: The World Bank, 1998:39-51.
137. Subramanian SV, Belli P, Kawachi I. The macroeconomic determinants of health. Annu Rev Public Health 2002;23:287-302.
138. Woodward D, Drager N, Beaglehole R, et al. Globalization and health: a framework for analysis and action. Bull World Health Organ 2001;79:875-81.
139. Lurie P, Hintzen P, Lowe RA. Socioeconomic obstacles to HIV prevention and treatment in developing countries: the roles of the International Monetary Fund and the World Bank. AIDS 1995;9:539-46.
140. Global HIV Prevention Working Group. Global mobilization for HIV prevention: a blueprint for action. 2002. (http:// www.gatesfoundation.org/nr/ downloads/globalhealth/aids/ hivprevreport_final.pdf). (Accessed September 16, 2003).
141. Global HIV Prevention Working Group. Access to HIV prevention: closing the gap. 2003. (http://www.gatesfoundation.org/nr/ downloads/globalhealth/aids/ PWGFundingReport.pdf). (Accessed September 16, 2003).
142. Ainsworth M, Beyrer C, Soucat A. AIDS and public policy: the lessons and challenges of 'success' in Thailand. Health Policy 2003;64:13-37.
143. Chavkin W, Wise PH. The data are in: health matters in welfare policy. Am J Public Health 2002;92:1392-5.
144. Crane J, Quirk K, van der Straten A. "Come back when you're dying": the commodification of AIDS among California's urban poor. Soc Sci Med 2002;55:1115-27.
145. White T. Controlling and policing substance use(rs). Subst Use Misuse 2002;37:973-83.
146. Koester SK. Copping, running, and paraphernalia laws-contextual variables and needle risk behavior among injection-drug users in Denver. Hum Organ 1994;53:286-95.
147. Maher L, Dixon D. Policing and public health-law enforcement and harm minimization in a street-level drug market. Br J Criminol 1999;39:488-512.
148. Rhodes T, Lowndes C, Judd A, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS 2002;16:F25-F31.
149. Strathdee SA, Zafar T, Brahmbhatt H, et al. Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war. Drug Alcohol Depend 2003;71:17-24.
150. Blumenthal RN, Lorvick J, Kral AH, et al. Collateral damage in the war on drugs: HIV risk behaviors among injection drug users. Int J Drug Policy 1999;10:25-38.
151. Kitayaporn D, Uneklabh C, Weniger BG, et al. HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS 1994;8:1443-50.
152. Choopanya K, Vanichseni S, Des Jarlais DC, et al. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS 1991;5:1509-13.
153. Brewer TF, Vlahov D, Taylor E, et al. Transmission of HIV-1 within a statewide prison system. AIDS 1988;2:363-7.
154. Taylor A, Goldberg D, Emslie J, et al. Outbreak of HIV infection in a Scottish prison. BMJ 1995;310:289-92.
155. Diaz RS, Kallas EG, Castelo A, et al. Use of a new 'less-sensitive enzyme immunoassay' testing strategy to identify recently infected persons in a Brazilian prison: estimation of incidence and epidemiological tracing. AIDS 1999;13:1417-18.
156. Dolan KA, Wodak A. HIV transmission in a prison system in an Australian state. Med J Aust 1999;171:14-17.
157. Edwards A, Curtis S, Sherrard J. Survey of risk behaviour and HIV prevalence in an English prison. Int J STD AIDS 1999;10:464-6.
158. Buavirat A, Page-Shafer K, van Griensven GJ, et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ 2003;326:308-13.
159. Choopanya K, Des Jarlais DC, Vanichseni S, et al. Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr 2002;29:86-94.
160. Hankins CA, Friedman SR, Zafar T, et al. Transmission and prevention of HIV and sexually transmitted infections in war settings: implications for current and future armed conflicts. AIDS 2002;16:2245-52.
161. Koopman JS. Emerging objectives and methods in epidemiology. Am J Public Health 1996;86:630-2.
162. Diez-Roux AV. Multilevel analysis in public health research. Annu Rev Public Health 2000;21:171-92.
163. Kaplan GA. What is the role of the social environment in understanding inequalities in health? Ann N Y Acad Sci 1999;896:116-19.
164. Krieger N. Epidemiology and the web of causation: has anyone seen the spider? Soc Sci Med 1994;39:887-903.
165. McMichael AJ. Prisoners of the proximate: loosening the constraints on epidemiology in an age of change. Am J Epidemiol 1999;149:887-97.
166. Schwartz S, Susser E, Susser M. A future for epidemiology? Annu Rev Public Health 1999;20:15-33.
167. Susser M, Susser E. Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemiology. Am J Public Health 1996;86:674-7.
168. Cromley EK. GIS and disease. Annu Rev Public Health 2003;24:7-24.
169. Rushton G. Public health, GIS, and spatial analytic tools. Annu Rev Public Health 2003;24:43-56.
170. Krieger N. Place, space, and health: GIS and epidemiology. Epidemiology 2003;14:384-5.
171. Krieger N, Waterman PD, Chen JT, et al. Monitoring socioeconomic inequalities in sexually transmitted infections, tuberculosis, and violence: geocoding and choice of area-based socioeconomic measures-the Public Health Disparities Geocoding Project (US). Public Health Rep 2003;118:240-60.
172. Krieger N, Chen JT, Waterman PD, et al. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The Public Health Disparities Geocoding Project. Am J Epidemiol 2002;156:471-82.
173. Parker RG. Empowerment, community mobilization and social change in the face of HIV/AIDS. AIDS 1996;10(suppl 3):S27-S31.
174. Waldo CR, Coates TJ. Multiple levels of analysis and intervention in HIV prevention science: exemplars and directions for new research. AIDS 2000;14(suppl 2):S18-S26.
175. Friedman SR, O'Reilly K. Sociocultural interventions at the community level. AIDS 1997;11(suppl A):S201-S208.
176. United National Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO). AIDS epidemic update: 2003. Geneva, Switzerland: WHO, 2003. (Publication no.UNAIDS/ 03.39E).
177. Harries AD, Nyangulu DS, Hargreaves NJ, et al. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001;358:410-14.
178. Farmer P, Leandre F, Mukherjee JS, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet 2001;358:404-9.
179. Ho DD, Huang Y. The HIV-1 vaccine race. Cell 2002;110:135-8.
180. Letvin NL, Barouch DH, Montefiori DC. Prospects for vaccine protection against HIV-1 infection and AIDS. Annu Rev Immunol 2002;20:73-99.
181. Krieger N. Theories for social epidemiology in the 21st century: an ecosocial perspective. Int J Epidemiol 2001;30:668-77.
182. Hanenberg RS, Rojanapithayakorn W, Kunasol P, et al. Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet 1994;344:243-5.
183. Phoolcharoen W, Ungchusak K, Sittitrai W, et al. Thailand: lessons from a strong national response to HIV/AIDS. AIDS 1998;12(suppl B):S123-S135.
184. Rojanapithayakorn W, Hanenberg R. The 100% condom program in Thailand. AIDS 1996;10:1-7.
185. Celentano DD, Galai N, Sethi AK, et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 2001;15:1707-15.
186. Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med 1998;339:1897-904.
187. Laufer FN. Cost-effectiveness of syringe exchange as an HIV prevention strategy. J Acquir Immune Defic Syndr 2001;28:273-8.
188. Lurie P, Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet 1997;349:604-8.
189. Weir SS, Pailman C, Mahlalela X, et al. From people to places: focusing AIDS prevention efforts where it matters most. AIDS 2003;17:895-903.
190. Sherman SG, Latkin CA. Intimate relationship characteristics associated with condom use among drug users and their sex partners: a multilevel analysis. Drug Alcohol Depend 2001;64:97-104.
191. Celentano DD, Bond KC, Lyles CM, et al. Preventive intervention to reduce sexually transmitted infections: a field trial in the Royal Thai Army. Arch Intern Med 2000;160:535-40.
192. Sweat M, Gregorich S, Sangiwa G, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000;356:113-21.
193. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Lancet 2000;356:103-12.
194. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-9.